Medclair AB (NGM:MCLR) Other Operating Expense: kr34.20 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NGM:MCLR Medclair AB NGM:MCLR
71 GF Score
Price kr2.90
GF Value kr2.35
Valuation Modestly Overvalued
View Full Analysis

What is Medclair AB Other Operating Expense?

Medclair AB NGM:MCLR -4.61% 71 Other Operating Expense is kr34.20 Mil as of Mar. 2026. GuruFocus rates NGM:MCLR with a GF Score™ of 71/100 and a GF Value™ of kr2.35 (Modestly Overvalued).

Medclair AB's Other Operating Expense for the three months ended in Mar. 2026 was kr9.32 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was kr34.20 Mil.

Medclair AB's quarterly Other Operating Expense increased from Sep. 2025 (kr7.24 Mil) to Dec. 2025 (kr8.88 Mil) and increased from Dec. 2025 (kr8.88 Mil) to Mar. 2026 (kr9.32 Mil).

Medclair AB's annual Other Operating Expense increased from Dec. 2023 (kr27.38 Mil) to Dec. 2024 (kr28.83 Mil) and increased from Dec. 2024 (kr28.83 Mil) to Dec. 2025 (kr31.88 Mil).

Medclair AB Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Medclair AB's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medclair AB Other Operating Expense Chart

Medclair AB Annual Data
Trend Apr16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.42 25.31 27.38 28.83 31.88

Medclair AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.03 8.76 7.24 8.88 9.32
NGM:MCLR
71GF Score
Medclair AB NGM:MCLR
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medclair AB Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr34.20 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of kr34.20 Mil mean?
Medclair AB (NGM:MCLR) has a Other Operating Expense of kr34.20 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on Medclair AB and its competitors.
Is Medclair AB's Other Operating Expense too high?
Medclair AB's current Other Operating Expense is kr34.20 Mil. Overall, Medclair AB has a GF Score™ of 71/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medclair AB's Other Operating Expense compare to ABT and SYK?
Medclair AB's Other Operating Expense of kr34.20 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Medical Devices & Instruments company?
A good Other Operating Expense depends on the Medical Devices & Instruments industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Medclair AB and its competitors. Medclair AB's current Other Operating Expense is kr34.20 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medclair AB stock overvalued right now?
Based on GuruFocus' analysis, Medclair AB (NGM:MCLR) is currently considered Modestly Overvalued. The stock's GF Value™ is kr2.35, compared to a current price of kr2.90 — trading 23.4% above its estimated fair value. The current Other Operating Expense is kr34.20 Mil. Medclair AB's overall GF Score™ is 71/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Medclair AB (NGM:MCLR), the current Other Operating Expense is kr34.20 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medclair AB (NGM:MCLR) Overvalued in 2026?

Based on GuruFocus' analysis, Medclair AB stock appears to be overvalued. The current stock price of kr2.90 is trading 23.4% above its estimated GF Value™ of kr2.35. GuruFocus considers Medclair AB to be Modestly Overvalued.

Key valuation signals for NGM:MCLR:

  • Other Operating Expense: kr34.20 Mil
  • GF Value™: kr2.35 vs. price of kr2.90 (23.4% above fair value)
  • GF Score™: 71/100

No single metric tells the full story. See the NGM:MCLR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medclair AB Business Description

Address Fraktflygargatan 1, Stockholm, SWE, 128 30
Medclair AB operates in healthcare industry. The company has two units: Central Destruction Unit (CDU) and Mobile Destruction Unit (MDU) decomposes the nitrous oxide entering the unit, transforming it to nitrogen (N2) och oxygen (O2). It also provide solutions for various N2O methods such as double mask, single mask, mouthpiece, or free flow, which ensures a safe work environment for healthcare professionals.
71GF Score

Get the complete analysis for NGM:MCLR

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.90
Price
kr2.35
GF Value